Full data on Novo Nordisk’s new amylin drug raise dosing questions The results of a Phase 1/2 study include unusual finding around dosage

https://www.statnews.com/2025/06/20/novo-nordisk-weight-loss-drug-amylin-hormone-injection-effective-but-side-effects-an-issue/